{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:20:27Z","timestamp":1791058827757,"version":"4.1.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1097\/01.bor.0000200369.24793.f5","type":"journal-article","created":{"date-parts":[[2005,12,12]],"date-time":"2005-12-12T04:01:29Z","timestamp":1134360089000},"page":"25-32","source":"Crossref","is-referenced-by-count":46,"title":["Advances in the therapy of Wegener's granulomatosis"],"prefix":"10.1097","volume":"18","author":[{"given":"Bernhard","family":"Hellmich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lamprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang L","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210128","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","article-title":"Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years","volume":"98","author":"Fauci","year":"1983","journal-title":"Ann Intern Med"},{"key":"R2-6-20210128","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener's granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/art.1780401213","article-title":"A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis","volume":"40","author":"Guillevin","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R4-6-20210128","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","article-title":"An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients","volume":"43","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R5-6-20210128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"R6-6-20210128","first-page":"195","article-title":"Randomised controlled trial of daily oral versus pulse cyclophosphamide for induction of remission in ANCA-associated systemic vasculitis [abstract]","volume":"28","author":"de Groot","year":"2005","journal-title":"Kidney Blood Press Res"},{"key":"R7-6-20210128","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/qjmed\/90.6.401","article-title":"Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis","volume":"90","author":"Adu","year":"1997","journal-title":"Q J Med"},{"key":"R8-6-20210128","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/ndt\/16.10.2018","article-title":"The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review","volume":"16","author":"de Groot","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R9-6-20210128","first-page":"492","article-title":"Induction of remission in Wegener's granulomatosis with low dose methotrexate","volume":"25","author":"de Groot","year":"1998","journal-title":"J Rheumatol"},{"key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/art.1780380505","article-title":"An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone","volume":"38","author":"Sneller","year":"1995","journal-title":"Arthritis Rheum"},{"key":"R11-6-20210128","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"de Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R12-6-20210128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.qjmed.a030133","article-title":"Response to trimethoprim\/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease","volume":"89","author":"Reinhold-Keller","year":"1996","journal-title":"Q J Med"},{"key":"R13-6-20210128","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1526-0968.2001.00300.x","article-title":"Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis","volume":"5","author":"Gaskin","year":"2001","journal-title":"Ther Apher"},{"key":"R14-6-20210128","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1001\/archinte.1993.00410230060008","article-title":"Practice guidelines: a new reality in medicine. III. Impact on patient care","volume":"153","author":"Woolf","year":"1993","journal-title":"Arch Intern Med"},{"key":"R15-6-20210128","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/art.1780391215","article-title":"Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis: methotrexate versus trimethoprim\/sulfamethoxazole","volume":"39","author":"de Groot","year":"1996","journal-title":"Arthritis Rheum"},{"key":"R16-6-20210128","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/1529-0131(199912)42:12<2666::AID-ANR24>3.0.CO;2-E","article-title":"A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance","volume":"42","author":"Langford","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R17-6-20210128","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/art.10459","article-title":"High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate","volume":"47","author":"Reinhold-Keller","year":"2002","journal-title":"Arthritis Care Res"},{"issue":"Suppl 3","key":"R18-6-20210128","first-page":"85","article-title":"Leflunomide versus methotrexate for maintenance of remission in Wegener's granulomatosis: unexpected high relapse rate under oral methotrexate","volume":"64","author":"Metzler","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R19-6-20210128","first-page":"339","article-title":"Maintenance of remission with leflunomide in Wegener's granulomatosis","volume":"63","author":"Metzler","year":"2004","journal-title":"Rheumatology"},{"key":"R20-6-20210128","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199607043350103","article-title":"Trimethoprim\u2013sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group","volume":"335","author":"Stegeman","year":"1996","journal-title":"N Engl J Med"},{"key":"R21-6-20210128","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1681\/ASN.V1091965","article-title":"Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement","volume":"10","author":"Nowack","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R22-6-20210128","doi-asserted-by":"crossref","first-page":"421","DOI":"10.5414\/CNP57421","article-title":"Tolerance of mycophenolate mofetil in end-stage renal disease patients with ANCA-assocaited vasculitis","volume":"57","author":"Haubitz","year":"2002","journal-title":"Clin Nephrol"},{"key":"R23-6-20210128","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.20240","article-title":"Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis","volume":"51","author":"Langford","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R24-6-20210128","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ndt\/gfh763","article-title":"Prolonged treatment of refractory Wegener's granulomatosis with 15-deoxyspergualin: an open study in seven patients","volume":"20","author":"Schmitt","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl","key":"R25-6-20210128","first-page":"S229","article-title":"Comparison of disease activity measures for ANCA-associated vasculitis","volume":"50","author":"Merkel","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R26-6-20210128","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","article-title":"Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity","volume":"93","author":"Jayne","year":"2000","journal-title":"Q J Med"},{"key":"R27-6-20210128","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/1529-0131(200105)44:5<1149::AID-ANR197>3.0.CO;2-F","article-title":"Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety","volume":"44","author":"Stone","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R28-6-20210128","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/rheumatology\/41.11.1303","article-title":"Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis","volume":"41","author":"Lamprecht","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"R29-6-20210128","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.ASN.0000114554.67106.28","article-title":"Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis","volume":"15","author":"Booth","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R30-6-20210128","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/art.20718","article-title":"Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"Keogh","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R31-6-20210128","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.ASN.0000048716.42876.14","article-title":"15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy","volume":"14","author":"Birck","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R32-6-20210128","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/rheumatology\/keh300","article-title":"High-dose intravenous azathioprine pulse treatment in refractory Wegener's granulomatosis","volume":"43","author":"Aries","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"R33-6-20210128","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1523-1755.2004.00534.x","article-title":"Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients","volume":"65","author":"Schmitt","year":"2004","journal-title":"Kidney Int"},{"key":"R34-6-20210128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-67-2-393","article-title":"The use of alcylating agents in the treatment of Wegener's granulomatosis","volume":"67","author":"Hollander","year":"1967","journal-title":"Ann Intern Med"},{"key":"R35-6-20210128","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bmj.2.5091.265","article-title":"Giant cell granuloma of the respiratory tract (Wegener's granulomatosis)","volume":"2","author":"Walton","year":"1958","journal-title":"BMJ"},{"key":"R36-6-20210128","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1136\/ard.2003.019125","article-title":"Urinary bladder cancer in Wegener's granulomatosis, risks and relation to cyclophosphamide","volume":"63","author":"Knight","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R37-6-20210128","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/1529-0131(199810)41:10<1835::AID-ART16>3.0.CO;2-Q","article-title":"Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study","volume":"41","author":"Haubitz","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R38-6-20210128","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9343(03)00077-9","article-title":"Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse","volume":"114","author":"Langford","year":"2003","journal-title":"Am J Med"},{"key":"R39-6-20210128","first-page":"194","article-title":"Treatment of ANCA-associated vasculitides: corticosteroids and pulse cyclophosphamide followed by maintenance therapy with methotrexate or azathioprine: a prospective multicenter randomized trial (Wegent) [abstract]","volume":"28","author":"Mahr","year":"2005","journal-title":"Kidney Blood Press Res"},{"key":"R40-6-20210128","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","article-title":"CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes","volume":"111","author":"Tiede","year":"2003","journal-title":"J Clin Invest"},{"key":"R41-6-20210128","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10067-004-1002-8","article-title":"High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide","volume":"24","author":"Benenson","year":"2005","journal-title":"Clin Rheumatol"},{"key":"R42-6-20210128","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00002281-200101000-00008","article-title":"Update on the European Vasculitis Study Group (EUVAS)","volume":"13","author":"Jayne","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"R43-6-20210128","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0197-2456(02)00209-X","article-title":"Design of the Wegeners granulomatosis etanercept trial (WGET).","volume":"23","year":"2002","journal-title":"Control Clin Trials"},{"key":"R44-6-20210128","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegeners granulomatosis.","volume":"352","year":"2005","journal-title":"N Engl J Med"},{"key":"R47-6-20210128","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/S0016-5085(03)00382-2","article-title":"Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease","volume":"124","author":"Van den Brande","year":"2003","journal-title":"Gastroenterology"},{"key":"R48-6-20210128","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","article-title":"Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients","volume":"41","author":"Bartolucci","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"R49-6-20210128","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/1529-0131(199904)42:4<751::AID-ANR19>3.0.CO;2-D","article-title":"Wegener's granulomatosis associated with renal cell carcinoma","volume":"42","author":"Tatsis","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R50-6-20210128","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/ard.2004.023937","article-title":"Urinary bladder cancer in Wegener's granulomatosis: is it more than cyclophosphamide?","volume":"63","author":"Hellmich","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R51-6-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.20717","article-title":"Rituximab and Wegener's granulomatosis: are B cells a target in vasculitis treatment?","volume":"52","author":"Sneller","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R52-6-20210128","first-page":"F","article-title":"Adjuctive plasma exchange is superior to methylprednisolone in acute renal failure due to ANCA-associated glomerulonephritis.","volume":"13","author":"Gaskin","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R53-6-20210128","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1053\/j.ajkd.2003.08.015","article-title":"Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis","volume":"42","author":"Klemmer","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R54-6-20210128","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.bor.0000160777.28259.c2","article-title":"Randomized controlled trials in vasculitis associated with anti-neutrophil cytoplasmic antibodies","volume":"17","author":"Goek","year":"2005","journal-title":"Curr Opin Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001665-201203000-00109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:05:15Z","timestamp":1785855915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-200601000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.bor.0000200369.24793.f5","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}